Back فرط النمو البكتيري في الأمعاء الدقيقة Arabic Sobrecreixement bacterià de l'intestí prim Catalan Dünndarmfehlbesiedlung German Sobrecrecimiento bacteriano intestinal Spanish Heste meharreko gainhazkuntza bakterianoaren sindrome Basque رشد بیش از اندازه باکتری روده باریک Persian Colonisation bactérienne chronique de l'intestin grêle French Síndrome de sobrecrecemento bacteriano Galician Sindrome da iperproliferazione batterica Italian Zespół rozrostu bakteryjnego jelita cienkiego Polish
| Small intestinal bacterial overgrowth | |
|---|---|
| Other names | bacterial overgrowth, small bowel bacterial overgrowth syndrome (SBBOS) |
 | |
| The ileocecal valve prevents reflux of bacteria from the colon into the small bowel. Resection of the valve can lead to bacterial overgrowth. | |
| Specialty | Gastroenterology  |
Small intestinal bacterial overgrowth (SIBO), also termed bacterial overgrowth, or small bowel bacterial overgrowth syndrome (SBBOS), is a disorder of excessive bacterial growth in the small intestine. Unlike the colon (or large bowel), which is rich with bacteria, the small bowel usually has fewer than 100,000 organisms per millilitre.[1] Patients with bacterial overgrowth typically develop symptoms which may include nausea, bloating, vomiting, diarrhea, malnutrition, weight loss, and malabsorption[2] by various mechanisms.
The diagnosis of bacterial overgrowth is made by a number of techniques, with the gold standard[3] being an aspirate from the jejunum that grows in excess of 105 bacteria per millilitre. Risk factors for the development of bacterial overgrowth include dysmotility; anatomical disturbances in the bowel, including fistulae, diverticula and blind loops created after surgery, and resection of the ileo-cecal valve; gastroenteritis-induced alterations to the small intestine; and the use of certain medications, including proton pump inhibitors.
Small bowel bacterial overgrowth syndrome is treated with an elemental diet or antibiotics, which may be given in a cyclic fashion to prevent tolerance to the antibiotics, sometimes followed by prokinetic drugs to prevent recurrence if dysmotility is a suspected cause.
- ^ Finegold SM (June 1969). "Intestinal Bacteria — The Role They Play in Normal Physiology, Pathologic Physiology, and Infection". Western Journal of Medicine. 110 (6): 455 –4 59. PMC 1503548. PMID 5789139.
- ^ Bures J, Cyrany J, Kohoutova D, Förstl M, Rejchrt S, Kvetina J, et al. (June 2010). "Small intestinal bacterial overgrowth syndrome". World Journal of Gastroenterology. 16 (24): 2978–90. doi:10.3748/wjg.v16.i24.2978. PMC 2890937. PMID 20572300.
- ^ Ghoshal UC, Ghoshal U, Das K, Misra A (January–February 2006). "Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in malabsorption syndrome and its relationship with oro-cecal transit time". Indian Journal of Gastroenterology. 25 (1): 6–10. PMID 16567886. Archived from the original on 2022-06-10. Retrieved 2021-05-22.